Return to Publications  |  Return to CINJ Home
Rutgers Cancer Institute of New Jersey's Cancer Connection, June 2014
Donate NowThe latest news on research, treatment, prevention and education from the
state's only National Cancer Institute-designated Comprehensive Cancer Center
Exploring Immunotherapy in Cancer Treatment

 

Kaufman

Research led by Howard L. Kaufman, MD, FACS, associate director for clinical science and chief surgical officer at Rutgers Cancer Institute of New Jersey, shows advanced-stage melanoma patients have significant improvement in response rate and a trend toward improved survival when treated with a genetically-modified form of a herpes virus. Dr. Kaufman, who is also a professor of surgery at Rutgers Robert Wood Johnson Medical School, presented on this Phase III global study at the recent American Society of Clinical Oncology Annual Meeting.Learn more

Cancer Institute of New Jersey Leader Named Executive Officer of Big Ten Cancer Research Consortium

 

Goodin

Susan Goodin, PharmD, executive director of statewide affairs at Rutgers Cancer Institute of New Jersey, has been named as Executive Officer to the Big Ten Cancer Research Consortium. Dr. Goodin, who is also a professor of medicine at Rutgers Robert Wood Johnson Medical School, will work closely with consortium members in the development of national cancer clinical trials stemming from collaborative science.Learn more

Helping Melanoma Survivors Engage in Sun Protection Behaviors through a Web Tool

 

Coups

Even though melanoma patients are at an increased risk of disease recurrence, research from Rutgers Cancer Institute of New Jersey shows that many patients do not perform a regular, thorough self-exam of their skin or sufficiently engage in sun protection behaviors. To address these concerns, Cancer Institute of New Jersey behavioral scientist Elliot J. Coups, PhD, who is also an associate professor of medicine at Rutgers Robert Wood Johnson Medical School, will explore developing a web-based intervention for this group with the help of a $2.5 million grant from the National Cancer Institute.Learn more

Improved Methods to Identify Frequent E-Cigarette Users is Needed

 

e-cigarette

As the prevalence of electronic cigarettes (e-cigarettes) continues to grow, research from investigators at the Cancer Institute of New Jersey and Rutgers School of Public Health shows more defined survey measurements are needed to better identify established users. Cristine Delnevo, PhD, MPH, co-leader of the Cancer Prevention and Control Program at the Cancer Institute, says it is key to delineate experimental or ever use from adoption or established use.Learn more

            Rutgers Cancer Institute of New Jersey                                          NCI logo 

Office of Communications         ·         www.cinj.org        ·        732-235-9871

                        Like us on Facebook                     Join the CINJ Mailing List